CRD-TMH-001 ( DrugBank: - )
1 disease
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 113 | 筋ジストロフィー | 1 |
113. 筋ジストロフィー
臨床試験数 : 646 / 薬物数 : 471 - (DrugBank : 105) / 標的遺伝子数 : 59 - 標的パスウェイ数 : 170
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05514249 (ClinicalTrials.gov) | August 31, 2022 | 11/8/2022 | Treatment of a Single Patient With CRD-TMH-001 | Treatment of a Single Patient With CRD-TMH-001 | Duchenne Muscular Dystrophy | Drug: CRD-TMH-001 | Cure Rare Disease, Inc | University of Massachusetts, Worcester | Active, not recruiting | 18 Years | 28 Years | Male | 1 | Phase 1 | United States |